MRSA檢測市場規模、佔有率和成長分析（按產品類型、檢測類型、最終用戶和地區分類）－2026-2033年產業預測

預計到 2024 年，全球 MRSA 檢測市場規模將達到 46.8 億美元，到 2025 年將達到 48.8 億美元，到 2033 年將達到 67.3 億美元，預測期（2026-2033 年）的複合年成長率為 4.1%。

醫療保健領域對快速識別和管理抗藥性細菌感染疾病的迫切需求，推動了全球耐甲氧西林金黃色葡萄球菌（MRSA）檢測市場的顯著成長。抗藥性金黃色葡萄球菌（MRSA）構成重大的公共衛生挑戰，特別是因為它對多種抗生素具有抗藥性，並導致醫院感染。社區和醫療機構中MRSA感染疾病的上升顯著增加了對準確快速診斷方法的需求。醫院和門診機構加強感染控制措施是推動市場成長的關鍵因素。此外，就地檢驗、分子診斷和自動化平台的進步使得MRSA的檢測速度更快、更準確。公眾意識的提高和常規篩檢監管要求的訂定，也進一步推動了市場動態，確保MRSA檢測在全球感染控制策略中發揮關鍵作用。

全球耐甲氧西林金黃色葡萄球菌（MRSA）檢測市場促進因素

抗生素抗藥性細菌（尤其是抗甲氧西林金黃色葡萄球菌 (MRSA) 和耐萬古黴素金黃色葡萄球菌 (VRSA)）的日益流行，導致醫院感染激增，尤其是在加護病房和透析中心等高風險環境中。住院時間延長和侵入性醫療操作等因素進一步加劇了這種情況。各衛生組織發布的關於 MRSA 定植的令人擔憂的統計數據凸顯了改善感染控制策略的緊迫性。市場致力於加強診斷和檢測能力，其驅動力正是有效對抗這些頑固病原體並保護患者健康的迫切需求。

限制全球耐甲氧西林金黃色葡萄球菌（MRSA）檢測市場的因素

由於耐甲氧西林金黃色葡萄球菌（MRSA）對病人安全，尤其是依賴醫療服務的弱勢群體，有著重大影響，因此全球MRSA檢測市場面臨許多限制因素。 MRSA的傳播途徑包括直接接觸和使用醫療設備。此外，醫療保健以外的行業，例如電信和電子行業，在表面黏著技術（SMT）和印刷基板（PCB）組裝等過程中也面臨污染風險。這凸顯了各行各業迫切需要採取有效的感染預防措施，同時也凸顯了在不同環境中控制MRSA的複雜性和挑戰性。

全球耐甲氧西林金黃色葡萄球菌（MRSA）檢測市場趨勢

全球耐甲氧西林金黃色葡萄球菌（MRSA）檢測市場目前正呈現出顯著的趨勢，即整合人工智慧（AI）診斷平台。這項創新技術透過自動化結果解讀和加速影像分析，正在變革傳統的診斷流程，進而提高檢測準確率。 AI技術的應用不僅縮短了檢測結果的報告時間，還提高了檢查室效率，使醫療機構能夠更早採取感染控制措施，尤其是在高風險環境中。隨著對快速、準確的MRSA檢測需求不斷成長，這些先進工具的應用預計將在未來感染疾病控制領域發揮關鍵作用。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 技術分析

全球耐甲氧西林金黃色葡萄球菌（MRSA）檢測市場規模（按產品類型和複合年成長率分類）（2026-2033 年）

• 裝置
• 試劑和試劑盒

全球耐甲氧西林金黃色葡萄球菌（MRSA）檢測市場規模（按檢測類型和複合年成長率分類）（2026-2033 年）

• 免疫診斷測試
• 分子診斷測試

全球耐甲氧西林金黃色葡萄球菌（MRSA）檢測市場規模（按最終用戶和複合年成長率分類）（2026-2033 年）

• 醫院
• 診斷檢查室
• 學術研究機構

全球耐甲氧西林金黃色葡萄球菌（MRSA）檢測市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• 3M Co.
• Abbott Laboratories
• ALIFAX Srl
• Arlington Scientific Inc.
• Becton Dickinson and Co.
• bioMerieux SA
• Bio Rad Laboratories Inc.
• Bruker Corp.
• Creative Diagnostics
• Danaher Corp.
• DiaSorin Spa
• Eurofins Scientific SE
• F. Hoffmann La Roche Ltd.
• GENSPEED Biotech GmbH
• OpGen Inc.
• Puritan Medical Products Co.
• R Biopharm AG
• Sekisui Diagnostics LLC
• Uniogen Oy
• ZeptoMetrix LLC

結論與建議

Global MRSA Testing Market size was valued at USD 4.68 Billion in 2024 and is poised to grow from USD 4.88 Billion in 2025 to USD 6.73 Billion by 2033, growing at a CAGR of 4.1% during the forecast period (2026-2033).

The global MRSA testing market is witnessing substantial growth, driven by the healthcare sector's urgent focus on the rapid identification and management of antibiotic-resistant infections. Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health challenge, particularly as it contributes to hospital-acquired infections while resisting multiple antibiotics. The rising incidence of MRSA infections across community and healthcare environments has significantly heightened the demand for accurate and timely diagnostics. Enhanced infection control measures in hospitals and outpatient facilities are crucial market catalysts. Additionally, advancements in point-of-care testing, molecular diagnostics, and automated platforms facilitate quicker and more precise detection of MRSA. Increased awareness and regulatory mandates for routine screenings further boost market dynamics, ensuring MRSA testing's vital role in global infection control strategies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global MRSA Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global MRSA Testing Market Segments Analysis

Global MRSA Testing Market is segmented by Product Type, Test Type, End user and region. Based on Product Type, the market is segmented into Instruments and Reagents & Kits. Based on Test Type, the market is segmented into Immunodiagnostic Test and Molecular Diagnostic Test. Based on End user, the market is segmented into Hospitals, Diagnostic Laboratories and Academic and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global MRSA Testing Market

The increasing prevalence of antibiotic-resistant bacteria, particularly MRSA and VRSA, is leading to a surge in hospital-acquired infections, particularly in high-risk environments such as intensive care units and dialysis centers. Factors such as prolonged hospital stays and the occurrence of invasive medical procedures further exacerbate the situation. This scenario underscores the urgent need for improved infection control strategies, as evidenced by concerning statistics on MRSA colonization released by various health organizations. The focus on enhancing diagnostic and testing capabilities in the market is driven by the necessity to combat these resilient pathogens effectively and safeguard patient health.

Restraints in the Global MRSA Testing Market

The global MRSA testing market faces various limitations, primarily due to the critical implications of MRSA for patient safety, particularly among vulnerable groups reliant on healthcare services. The transmission of MRSA occurs both via direct contact and through the use of medical devices. Moreover, sectors beyond healthcare, including telecommunications and electronics, experience contamination risks during processes like surface-mount technology (SMT) and printed circuit board (PCB) assembly. This highlights a pressing need for effective infection prevention measures across all industries, underscoring the complexity and challenges in addressing MRSA control in diverse environments.

Market Trends of the Global MRSA Testing Market

The Global MRSA Testing market is currently experiencing a significant trend towards the integration of AI-powered diagnostic platforms. This innovation is transforming traditional diagnostic workflows by automating result interpretation and expediting image analysis, which in turn enhances detection accuracy. The implementation of AI technologies is not only minimizing turnaround times but also boosting laboratory efficiency, making it possible for healthcare providers to implement earlier infection control measures, particularly in high-risk environments. As the demand for rapid and precise MRSA testing grows, the adoption of these advanced tools is expected to play a pivotal role in shaping the future landscape of infectious disease management.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Analysis

Global MRSA Testing Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Instruments
• Reagents & Kits

Global MRSA Testing Market Size by Test Type & CAGR (2026-2033)

• Market Overview
• Immunodiagnostic Test
• Molecular Diagnostic Test

Global MRSA Testing Market Size by End user & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Academic and Research Institutes

Global MRSA Testing Market Size & CAGR (2026-2033)

• North America (Product Type, Test Type, End user)
  • US
  • Canada
• Europe (Product Type, Test Type, End user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Test Type, End user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Test Type, End user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Test Type, End user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• 3M Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ALIFAX Srl
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arlington Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton Dickinson and Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio Rad Laboratories Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corp.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corp.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin Spa
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GENSPEED Biotech GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OpGen Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Puritan Medical Products Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• R Biopharm AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui Diagnostics LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Uniogen Oy
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZeptoMetrix LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations